Evidence map›Paper›PMID 42781644›Full record

ArticleJournal of cardiovascular echography

How to Do Echo in Left Ventricular Hypertrophy: A Consensus Statement of the Italian Society of Echocardiography and Cardiovascular Imaging.

Antonio De Luca, Alessandro Folgheraiter, Thomas Caiffa, Aldostefano Porcari, Matteo Cameli, Eustachio Agricola, Maurizio Cusmà Piccione, Roberta Manganaro, Andrea Barison, Giancarlo Todiere and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiovascular echography. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Antonio De LucaCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy.
Alessandro FolgheraiterCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy.
Thomas CaiffaDepartment of Paediatrics, Institute for Maternal and Child Health - IRCCS 'Burlo Garofolo', Trieste, Italy.
Aldostefano PorcariCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy.
Matteo CameliDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.
Eustachio AgricolaUnit of Cardiovascular Imaging, IRCCS San Raffaele Hospital, Milan, Italy.
Maurizio Cusmà PiccioneDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Roberta ManganaroDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Andrea BarisonDivision of Cardiology, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
Giancarlo TodiereDivision of Cardiology, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
Giuseppe PalmieroInherited and Rare Cardiovascular Disease, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Monaldi Hospitatl, Naples, Italy.
Gianluca Di BellaDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Marco MerloCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy.
Gianfranco SinagraCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy.
Scipione CarerjDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Concetta ZitoDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
This Document was Promoted by Members of the 2024-2026 SIECVI Scientific Documents Committee and Reviewed by
Ilaria CasoDepartment of Cardiology, Monaldi Hospital, Naples, Italy.
Antonella MoreoCardiology IV, "A. De Gasperis" Department, Niguarda Ca' Granda Hospital, Milan, Italy.
Mauro PepiCardiology IV, "A. De Gasperis" Department, Niguarda Ca' Granda Hospital, Milan, Italy.
2024-2026 SIECVI Board

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Left ventricular hypertrophy (LVH) is defined by increased left ventricular wall thickness and/or mass and reflects a heterogeneous spectrum of primary myocardial diseases or an adaptive response to pressure or volume overload. Multimodality imaging, integrated with comprehensive clinical assessment, electrocardiography, and laboratory testing, plays a central role in the noninvasive evaluation of LVH [Graphical Abstract]. Echocardiography represents the first-line imaging modality for initial assessment and serial follow-up, providing comprehensive structural and functional information. Cardiac magnetic resonance imaging provides diagnostic confirmation and enables etiologic differentiation through advanced tissue characterization. Other imaging modalities, particularly nuclear medicine techniques, are employed in specific clinical contexts such as the evaluation of cardiac amyloidosis.

Indexed as

Echocardiographyhypertrophic cardiomyopathyleft ventricular hypertrophymultimodality imagingphenocopies

Identifiers

PMID42781644
PMCPMC13600627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.